Moreover, a correlation between elevated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation/phosphorylation and upregulated MDR efflux transporter expression was demonstrated in doxorubicin-resistant breast cancer cells [92]. Here, NFKB1 is linked to breast carcinoma.